Hollyweed is a modern hybrid-indica strain whose exact origins remain undocumented. While the strain is associated with 88 G-13 HashPlant, its broader lineage is debated and breeders have not provided a definitive history or official description of its initial creation. Due to this lack of documentation, the circumstances surrounding its emergence remain unclear, serving as a reminder that the history of many contemporary hybrids is often fragmented or incomplete.

The chemical composition of Hollyweed is characterized by a complex terpene profile dominated by myrcene, followed by pinene, ocimene, limonene, caryophyllene, beta-pinene, linalool, humulene, guaiol, bisabolol, nerolidol, and camphene. Users can expect an estimated cannabinoid content of 24.1% THC, with negligible amounts of CBD and roughly 0.15% CBG. This combination of terpenes likely contributes to a sophisticated aromatic and flavor experience, though specific sensory notes are subjective and correspond to these confirmed chemical constituents.

In terms of effects, Hollyweed produces a state of relaxation while maintaining user focus. It is frequently employed as an aid for managing pain and stress, and is also often utilized to support sleep. Cultivators will find the strain requires moderate experience to grow successfully, with a flowering time of 60 days. It thrives in both indoor and outdoor environments and is recognized for producing a high yield. At this time, there is no record of notable offspring derived from this variety.